
Karuna Therapeutics KRTX
Annual report 2023
added 02-22-2024
Karuna Therapeutics EBITDA per Share 2011-2026 | KRTX
Annual EBITDA per Share Karuna Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.3 | -9.12 | -4.92 | -2.71 | -3.79 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.71 | -13.3 | -6.78 |
Quarterly EBITDA per Share Karuna Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -3.12 | - | -2.48 | -2.16 | -1.96 | - | -1.72 | -1.17 | -1.07 | - | -0.73 | -0.68 | -0.39 | - | -0.43 | -145 | -4.32 K | - | -494 K | -202 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.39 | -494 K | -46.7 K |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-0.11 | - | -15.15 % | $ 60.3 M | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Aptorum Group Limited
APM
|
0.34 | $ 0.83 | 2.17 % | $ 4.53 M | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
BioNTech SE
BNTX
|
62.6 | $ 110.14 | 3.3 % | $ 27.2 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
-0.63 | $ 2.6 | -1.12 % | $ 146 M | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | ||
|
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.51 | -0.52 % | $ 8.45 B | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.01 | $ 4.21 | 1.2 % | $ 9.16 B | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
-0.24 | $ 1.49 | 7.19 % | $ 279 M | ||
|
Aptose Biosciences
APTO
|
0.05 | - | -45.71 % | $ 1.2 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-8.25 | $ 221.8 | -0.16 % | $ 5 B | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Arena Pharmaceuticals
ARNA
|
-10.2 | - | -6.81 % | $ 3.04 B | ||
|
Aridis Pharmaceuticals
ARDS
|
-1.57 | - | 17.91 % | $ 11.1 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 8.96 | 0.45 % | $ 1.41 B | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Athira Pharma
ATHA
|
-2.6 | - | - | $ 269 M | ||
|
Athersys
ATHX
|
-0.382 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Avenue Therapeutics
ATXI
|
-8.71 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-0.92 | $ 1.46 | 2.46 % | $ 373 M | ||
|
Amneal Pharmaceuticals
AMRX
|
1.01 | $ 14.49 | -0.24 % | $ 4.48 B | ||
|
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-0.39 | $ 2.35 | -1.81 % | $ 14.8 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B | ||
|
Brickell Biotech
BBI
|
-1.17 | - | -5.38 % | $ 6.06 M |